Rocket Pharmaceuticals, Inc. IPO Research Information

Rocket Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Rocket Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Rocket Pharmaceuticals, Inc.	RCKT -	Last Trade $13.51	$12.50	$0.00	13.2 million	12/11/2024
Underwriter(s): J.P. Morgan, Morgan Stanley, Leerink Partners, TD Cowen
Co-Manager(s):
Industry:
Filing(s):

Rocket Pharmaceuticals, Inc. Quote & Chart - Click for current quote - RCKT

About Rocket Pharmaceuticals, Inc. (adapted from Rocket Pharmaceuticals, Inc. prospectus):
They an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RCKT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.